A novel gene signature associated with poor response to chemoradiotherapy in patients with locally advanced cervical cancer.

Patients with cervical cancer having poor CCRT or RT outcomes exhibited a distinct gene signature that could predict treatment outcomes. For poor responders, immune checkpoint inhibitors may be less effective whereas CAF-targeting treatments may be a promising approach.